Skip to Content

Join the 'Prasterone' group to help and get support from people like you.

Prasterone News

FDA Approves Intrarosa (prasterone) for Postmenopausal Women Experiencing Dyspareunia

Posted 12 days ago by Drugs.com

November 17, 2016 – The U.S. Food and Drug Administration approved Intrarosa (prasterone) to treat women experiencing moderate to severe pain during sexual intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA), due to menopause. Intrarosa is the first FDA approved product containing the active ingredient prasterone, which is also known as dehydroepiandrosterone (DHEA). During menopause, levels of estrogen decline in vaginal tissues, which may cause a condition known as VVA, leading to symptoms such as pain during sexual intercourse. “Pain during sexual intercourse is one of the most frequent symptoms of VVA reported by postmenopausal women,” said Audrey Gassman, M.D., deputy director of the Division of Bone, Reproductive, and Urologic Products (DBRUP) in the Office of Drug Evaluation III in the FDA’s Center for Drug Evaluation and Research (CDER). “Intrarosa provide ... Read more

Related support groups: Menopausal Disorders, Postmenopausal Symptoms, Dyspareunia, Vaginal Dryness, Intrarosa, Prasterone

Ask a Question

Further Information

Related Condition Support Groups

Dyspareunia

Related Drug Support Groups

Intrarosa